Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000019922 | SCV000966994 | likely pathogenic | Reticular dysgenesis | 2018-09-26 | criteria provided, single submitter | clinical testing | The p.Arg103Trp variant in AK2 has been reported in the homozygous state in 2 in dividuals and the compound heterozygous state with a nonsense variant in 1 indiv idual with reticular dysgenesis (Lagresle-Peyrou 2009, Hoenig 2017). This varian t was absent from large population studies. In vivo studies, using fibroblasts d erived from one of the affected individuals homozygous for this variant, provide some evidence that the variant reduces expression levels (Lagresle-Peyrou 2009) ; however, these types of assays may not accurately represent biological functio n. Computational prediction tools and conservation analysis suggest that this va riant may impact the protein, though this information is not predictive enough t o determine pathogenicity. In summary, although additional studies are required to fully establish its clinical significance, the p.Arg103Trp variant is likely pathogenic. ACMG/AMP criteria applied: PM2, PM3, PP3, PP4. |
OMIM | RCV000019922 | SCV000040220 | pathogenic | Reticular dysgenesis | 2009-01-01 | no assertion criteria provided | literature only |